EU regulator conditionally approves Abbott's purchase of St Jude

Wed Nov 23, 2016 12:24pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' ABT.N bid for peer St Jude Medical Inc STJ.N.

Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.

The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."

(Reporting by Gabriela Baczynska)

 
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016.  REUTERS/Brendan McDermid/File Photo